Biohaven BHVN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $277.11M+170% | $232.78M+127% | $188.38M+114% | $169M-30.3% | $102.69M-45.1% | ||
| $74.74M-66.7% | $89.18M-76.9% | $75.37M-74.4% | $239.18M+20.9% | $224.33M+123% | ||
| $385.65M+0.8% | $368.33M-31.6% | $323.62M-26.5% | $474.83M-7.1% | $382.76M+9.8% | ||
| $15.26M-14.2% | $15.96M-7.8% | $17.52M-4.1% | $18.59M-0.4% | $17.79M+6.6% | ||
| $1.39M0.0% | $1.39M0.0% | $1.39M0.0% | $1.39M0.0% | $1.39M0.0% | ||
| $18.4M0.0% | $18.4M0.0% | $18.4M0.0% | $18.4M0.0% | $18.4M0.0% | ||
| $466.41M+1.6% | $451.45M-26.6% | $409.12M-19.9% | $550.42M-5.5% | $458.95M+9.7% | ||
| $59.18M-20.2% | $67.9M-25.7% | $74.29M-16.5% | $76.54M-2.8% | $74.17M+0.9% | ||
| $52.08M-68.3% | $115.93M-24.8% | $113.02M-25.8% | $124.32M-20.4% | $164.03M+89.4% | ||
| $241.91M— | —— | —— | —— | —— | ||
| $336.91M+68.9% | $399.38M+108% | $426.28M+119% | $415.83M+109% | $199.45M+70.3% | ||
| 200M0.0% | 200M-87.9% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$2.22B-41.3% | -$2.08B-54.9% | -$1.94B-67.3% | -$1.77B-76.8% | -$1.57B-131% | ||
| $129.5M-50.1% | $52.07M-87.7% | -$17.16M-105% | $134.59M-64.9% | $259.5M-13.9% | ||
| $466.41M+1.6% | $451.45M-26.6% | $409.12M-19.9% | $550.42M-5.5% | $458.95M+9.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Biohaven cover its short-term obligations?
- Its current ratio is 7.41 — current assets exceed current liabilities.
- Where does Biohaven's balance sheet data come from?
- Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.